Tevogen Bio Holdings Statistics
Total Valuation
TVGN has a market cap or net worth of $237.22 million. The enterprise value is $238.23 million.
Important Dates
The next estimated earnings date is Tuesday, June 10, 2025, before market open.
| Earnings Date | Jun 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TVGN has 183.89 million shares outstanding. The number of shares has increased by 424.97% in one year.
| Current Share Class | 183.89M |
| Shares Outstanding | 183.89M |
| Shares Change (YoY) | +424.97% |
| Shares Change (QoQ) | +51.29% |
| Owned by Insiders (%) | 89.73% |
| Owned by Institutions (%) | 2.13% |
| Float | 18.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35
| Current Ratio | 0.35 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -651.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -578.29% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 740.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.74M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.81% in the last 52 weeks. The beta is -0.80, so TVGN's price volatility has been lower than the market average.
| Beta (5Y) | -0.80 |
| 52-Week Price Change | +59.81% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 62.29 |
| Average Volume (20 Days) | 652,067 |
Short Selling Information
The latest short interest is 1.90 million, so 1.03% of the outstanding shares have been sold short.
| Short Interest | 1.90M |
| Short Previous Month | 3.22M |
| Short % of Shares Out | 1.03% |
| Short % of Float | 10.06% |
| Short Ratio (days to cover) | 1.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -34.40M |
| Pretax Income | -51.21M |
| Net Income | -31.28M |
| EBITDA | -34.24M |
| EBIT | -34.40M |
| Earnings Per Share (EPS) | -$0.20 |
Full Income StatementBalance Sheet
The company has $1.97 million in cash and $4.82 million in debt, giving a net cash position of -$2.85 million or -$0.02 per share.
| Cash & Cash Equivalents | 1.97M |
| Total Debt | 4.82M |
| Net Cash | -2.85M |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -7.72M |
| Book Value Per Share | -0.09 |
| Working Capital | -5.64M |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.14M |
| Capital Expenditures | n/a |
| Free Cash Flow | -13.14M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |